| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 589 | 2015 |
| Genome-wide association studies identify four ER negative–specific breast cancer risk loci M Garcia-Closas, FJ Couch, S Lindstrom, K Michailidou, MK Schmidt, ... Nature genetics 45 (4), 392-398, 2013 | 482 | 2013 |
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer CA Haiman, GK Chen, CM Vachon, F Canzian, A Dunning, RC Millikan, ... Nature genetics 43 (12), 1210-1214, 2011 | 360 | 2011 |
| Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors C Tarn, L Rink, E Merkel, D Flieder, H Pathak, D Koumbi, JR Testa, ... Proceedings of the National Academy of Sciences 105 (24), 8387-8392, 2008 | 298 | 2008 |
| A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11 A Siddiq, FJ Couch, GK Chen, S Lindström, D Eccles, RC Millikan, ... Human molecular genetics 21 (24), 5373-5384, 2012 | 220 | 2012 |
| Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase LL Marcotte, AB Wass, DW Gohara, HB Pathak, JJ Arnold, DJ Filman, ... Journal of virology 81 (7), 3583-3596, 2007 | 155 | 2007 |
| Common breast cancer susceptibility loci are associated with triple-negative breast cancer KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick, C Olswold, ... Cancer research 71 (19), 6240-6249, 2011 | 152 | 2011 |
| 19p13. 1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus KN Stevens, Z Fredericksen, CM Vachon, X Wang, S Margolin, ... Cancer research 72 (7), 1795-1803, 2012 | 134 | 2012 |
| Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion TV Do, F Xiao, LE Bickel, AJ Klein-Szanto, HB Pathak, X Hua, C Howe, ... Oncogene 33 (5), 539-549, 2014 | 124 | 2014 |
| Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash RJ Schilder, HB Pathak, AE Lokshin, RW Holloway, RD Alvarez, ... Gynecologic oncology 113 (1), 21-27, 2009 | 120 | 2009 |
| Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG … P Sharma, WE Barlow, AK Godwin, H Pathak, K Isakova, D Williams, ... Annals of Oncology 29 (3), 654-660, 2018 | 106 | 2018 |
| Structure-function relationships of the RNA-dependent RNA polymerase from poliovirus (3Dpol): a surface of the primary oligomerization domain functions in capsid precursor … HB Pathak, SKB Ghosh, AW Roberts, SD Sharma, JD Yoder, JJ Arnold, ... Journal of Biological Chemistry 277 (35), 31551-31562, 2002 | 100 | 2002 |
| Picornavirus genome replication: assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex HB Pathak, JJ Arnold, PN Wiegand, MRS Hargittai, CE Cameron Journal of Biological Chemistry 282 (22), 16202-16213, 2007 | 95 | 2007 |
| Picornavirus genome replication: roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation HB Pathak, HS Oh, IG Goodfellow, JJ Arnold, CE Cameron Journal of Biological Chemistry 283 (45), 30677-30688, 2008 | 87 | 2008 |
| Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study RJ Schilder, WE Brady, HA Lankes, JV Fiorica, MS Shahin, XC Zhou, ... Gynecologic oncology 127 (1), 70-74, 2012 | 85 | 2012 |
| Proteinase-polymerase precursor as the active form of feline calicivirus RNA-dependent RNA polymerase L Wei, JS Huhn, A Mory, HB Pathak, SV Sosnovtsev, KY Green, ... Journal of virology 75 (3), 1211-1219, 2001 | 84 | 2001 |
| Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers SJ Ramus, AC Antoniou, KB Kuchenbaecker, P Soucy, J Beesley, X Chen, ... Human mutation 33 (4), 690-702, 2012 | 63 | 2012 |
| WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1 M Li, R Soder, S Abhyankar, H Abdelhakim, MW Braun, CV Trinidad, ... Journal of extracellular vesicles 10 (4), e12067, 2021 | 59 | 2021 |
| Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer … P Sharma, E Rodler, WE Barlow, J Gralow, SL Huggins-Puhalla, ... Journal of Clinical Oncology 38 (15_suppl), 1001-1001, 2020 | 59 | 2020 |
| An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer G Sethi, HB Pathak, H Zhang, Y Zhou, MB Einarson, V Vathipadiekal, ... Public Library of Science 7 (10), e47086, 2012 | 56 | 2012 |
